Krystal Biotech, Inc.
- KRYS
- NASDAQ
- Biotechnology
- Gene Therapy
- Orphan Disease Treatments
$316.58
Today −4.07%Quote Oct 16, 2026, 08:00 PM UTC
−6.54%over the last month
Max drawdown −9.8%From 1-month high −9.8%3 months −6.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$9.37B
Quote Oct 16
Next earnings
Nov 2
Expected, not confirmed
Analyst target
$395.20
+24.8% from here
Floor
$310.18
2.0% below price
Where the price sits
17 analysts
Analyst range, low to high
$300.00$474.00
- Price $316.58
- Resistance $318.29–$321.49
- Consensus $395.20
The price is right under resistance. Analysts' average target sits about 25% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about KRYSPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
295